• Stacks Image 13742

Annual APMG Advance Meetings

Stacks Image 11218
Affiliated Pathologists Medical Group embarked on a Strategic Planning effort in 2011 which culminated in July with a full day seminar called Advance 1.0. We were going to call the event a Retreat but Advance is a much better term to convey the goals and flavor of the event). The meeting represented our year-round commitment to improving the quality of our service; APMG Advance 2.0, 3.0, 4.0 and 5.0 followed in subsequent years.

Presentations were given by Four Task Forces.  We had broad participation in the process—72% of the APMG Members actively participated in strategic planning over a six month period and thirty-three of thirty-five members attended the meeting. The following years, Advance 2.0 and 3.0 featured team building exercises, report out sessions from each work group, and software demonstrations. Our Advance 6.0 is scheduled for summer 2016.

APMG Advance

APMG Advance 5.0
August 15-16th, 2015
Long Beach, CA

Affiliated Pathologists Medical Group holds a two-day meeting every year. The topics are wide-ranging and all pathologists participate. Work Groups are formed the beginning of the year and each group reports on their findings at the Advance. A video compilation from one of our prior meetings, Advance 3.0, is shown below from 2013.

You can also view photos from the event on our Flickr page.







Molecular Pathology

Primary Objective:
To create a useful and easily accessible centralized database of information for molecular pathology testing on the APMG website.

Specific goals for website content are to provide:
  • an up-to-date listing of all currently available molecular tests for both neoplastic and non-neoplastic diseases
  • a reference information for molecular tests including normal pathways, alterations associated with disease, and their relationship to clinical therapies.
  • a database of laboratories currently offering molecular tests, complete with specimen requirements, estimated costs, and turnaround times.
  • Provide lists of clinical indications for determining which patients may benefit from molecular testing.
  • testing algorithms to guide appropriate ordering of molecular tests based upon current guidelines.
  • examples of how each test should be interpreted and reported.
  • standardized molecular testing comments for use on pathology reports. 
  • a listing of useful reference sites and other molecular pathology resources. 

Team
Saadiya Haque, DO  (lead)
James Harris, MD
Meredith L. Peake, MD
Jenny Galloway, MD
Ying Pei, MD
Matthew Fleming, MD
Robert Schmidt, MD
Eric F. Glassy, MD, FCAP 
Michelle Fajardo, MD

Presentations
Saadiya Haque, DO 
James Harris, MD 
Michelle Fajardo, MD

edge
edge
edge

Patient Reports

Team
Diane Tam-Singer, MD (lead)
Valerie McWhorter, MD
Alessandro DeVito MD
Alfred Yamamoto, MD
Matthew Fleming, MD
Robert Schmidt, MD
Eric F. Glassy, MD, FCAP 
Robin A. Moore MD
Presentation
Eric F. Glassy, MD, FCAP

edge
edge
edge
edge
edge

Consulting

Team
Hany Halawa, MD (lead)
Mary Beth Shwayder, MD
David Park, MD, PhD
Banafsheh Rashidi, MD
James Harris, MD
Thomas Hirose, MD
Gordana Stevanovic, MD
Michael Legmann, MD
Richard Ellis, MD
Eric F. Glassy, MD, FCAP 

Presentations
Hany Halawa, MD
David Park, MD, PhD
Eric F. Glassy, MD, FCAP 

edge
edge
edge
edge

In Vivo Microscopy

Team
Boris Skyar, MD (lead)
Saadiya Haque, DO
Norbert Jones, MD
Steve Ohsie, MD
Natash Kallichanda, MD
Presentations
Boris Skyar, MD

edge

Additional Presentations

edge
edge
edge